Inspire Medical Systems Inc [INSP] stock is trading at $96.2, up 1.85%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INSP shares have gain 4.04% over the last week, with a monthly amount glided 0.98%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on December 08, 2025, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $175 for it. Previously, Morgan Stanley downgraded its rating to Equal-Weight on December 02, 2025, and kept the price target unchanged to $130. On November 26, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $165 on the stock. Wolfe Research upgraded its rating to a Outperform but stick to its price target of $180 on November 25, 2025. Stifel upgraded its rating to a Buy. Wells Fargo upgraded its rating to Overweight for this stock on November 04, 2025, but kept the price target unchanged to $90. In a note dated October 24, 2025, Jefferies downgraded an Hold rating on this stock but restated the target price of $85.
Inspire Medical Systems Inc [INSP] stock has fluctuated between $70.77 and $203.12 over the past year. Currently, Wall Street analysts expect the stock to reach $146.23 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $96.2 at the most recent close of the market. An investor can expect a potential return of 52.01% based on the average INSP price forecast.
Analyzing the INSP fundamentals
Inspire Medical Systems Inc [NYSE:INSP] reported sales of 882.62M for the trailing twelve months, which represents a growth of 10.49%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.07 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Inspire Medical Systems Inc’s Current Ratio is 5.29. Also, the Quick Ratio is 4.01, while the Cash Ratio stands at 1.02. Considering the valuation of this stock, the price to sales ratio is 3.17, the price to book ratio is 4.19 and price to earnings (TTM) ratio is 65.98.
Transactions by insiders
Recent insider trading involved Rondoni John, that happened on Jan 09 ’26 when 109.0 shares were sold. Officer, JOHN RONDONI completed a deal on Jan 09 ’26 to buy 109.0 shares. Meanwhile, Director mcCormick Shawn sold 1200.0 shares on Dec 02 ’25.
